STO Equity Snapshot
ATORX Weekly Equity Report
Alligator Bioscience AB (publ)
What the company does
Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Belgium. The company develops Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 3 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer; and ATOR-4066, tumor-directed bispecific antibody, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage for the treatment of solid metastatic tumors. It also offers ALG.APV-527, a bispecific antibody that targets the 4-1BB and 5T4 molecules, which is in phase 2 clinical trial for the treatment of solid metastatic tumors; …
What the weekly tape is saying
ATORX closed the latest completed week at 0.18 SEK. The 4-week return is -20.9% and the 12-week return is -1.2%. Trend Signal is inactive, Market Dynamics is 1.09. Setup signature: Risk-first tape with a 13/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 0.27 SEK
- Vs Trend Line
- -33.5%
- Fair Value
- 38.85 SEK
- Vs Fair Value
- -99.5%
- 52W High
- 7.21 SEK
- 52W Low
- 0.16 SEK
- Drawdown
- -97.5%
- Range Position
- 0.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- SE Healthcare
- Sector Rank
- 144 of 158
- Sector Percentile
- 8.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 96 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Biotechnology
- Tracked Peers
- 59
- 4W Rank
- 53 of 59
- Avg 1W
- 3.1%
- Avg 4W
- -1.6%
- Trend Breadth
- 30.5%
- Positive RS
- 22.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.09
- 4W MD Change
- -26.1%
- Relative Strength
- -92.29
- 4W RS Change
- -1.0%
- Expectation
- Negative
- Probability
- 38.39%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 21.4M
- 13W Average
- 79.5M
- 52W Average
- 28.5M
- Vs 13W
- 0.3x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 21.7%
- 52W Volatility
- 22.5%
- Upside Weeks
- 20
- Downside Weeks
- 32
- Downside Breadth
- 61.5%
- Avg Gain / Loss
- 15.0% / -13.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- SEK
- Market Cap
- 128.8M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 0.18 SEK | -11.7% | 0.27 SEK | 38.85 SEK | 1.09 | -92.29 | 21.4M | Off |
| 5 Jun 2026 | 0.20 SEK | -1.7% | 0.30 SEK | 39.18 SEK | 1.27 | -91.59 | 14.3M | Off |
| 29 May 2026 | 0.20 SEK | -3.1% | 0.34 SEK | 39.45 SEK | 1.36 | -91.81 | 19.0M | Off |
| 22 May 2026 | 0.21 SEK | -6.0% | 0.39 SEK | 39.74 SEK | 1.39 | -91.90 | 29.5M | Off |
| 15 May 2026 | 0.23 SEK | 1.6% | 0.43 SEK | 40.01 SEK | 1.47 | -91.38 | 18.3M | Off |
| 8 May 2026 | 0.22 SEK | 4.5% | 0.53 SEK | 40.28 SEK | 1.55 | -91.89 | 54.0M | Off |
| 1 May 2026 | 0.21 SEK | -11.9% | 0.67 SEK | 40.60 SEK | 1.59 | -92.47 | 33.7M | Off |
| 24 Apr 2026 | 0.24 SEK | -22.3% | 0.81 SEK | 40.87 SEK | 1.54 | -91.84 | 201.4M | Off |
| 17 Apr 2026 | 0.31 SEK | 71.8% | 0.97 SEK | 41.19 SEK | 1.44 | -90.14 | 539.8M | Off |
| 10 Apr 2026 | 0.18 SEK | 6.0% | 1.09 SEK | 41.53 SEK | 1.36 | -94.37 | 52.9M | Off |
| 3 Apr 2026 | 0.17 SEK | 0.2% | 1.23 SEK | 41.87 SEK | 1.37 | -94.70 | 14.8M | Off |
| 27 Mar 2026 | 0.17 SEK | -5.8% | 1.36 SEK | 42.17 SEK | 1.32 | -94.74 | 11.2M | Off |
| 20 Mar 2026 | 0.18 SEK | -9.0% | 1.50 SEK | 42.41 SEK | 1.29 | -94.67 | 23.8M | Off |
| 13 Mar 2026 | 0.20 SEK | 1.1% | 1.64 SEK | 42.64 SEK | 1.19 | -94.69 | 40.1M | Off |